REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoeconomic analysis, which structure and interpretatio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
Natura: Artigo
Lingua:Russo
Pubblicazione: IRBIS LLC 2015-09-01
Serie:Фармакоэкономика
Soggetti:
pharmacoeconomics
orphan drugs
rare diseases
cost-utility analysis
Accesso online:https://www.pharmacoeconomics.ru/jour/article/view/98
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi